[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G2/M phase and apoptosis

被引:53
作者
Pojarova, Michaela [1 ]
Kaufmann, Doris [1 ]
Gastpar, Robert [1 ]
Nishino, Tsuyuki [1 ]
Reszka, Przemyslaw [2 ]
Bednarski, Patrick J. [2 ]
von Angerer, Erwin [1 ]
机构
[1] Univ Regensburg, Inst Pharm, D-93040 Regensburg, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany
关键词
phenylindoles; breast cancer; cell cycle arrest; apoptosis;
D O I
10.1016/j.bmc.2007.07.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell cycle arrest of malignant cells is an important option for cancer treatment. In this study, we modified the structure of antimitotic 2-phenylindole-3-carbaldehydes by condensation with malononitrile. The resulting methylene propanedinitriles inhibited the growth of MDA-MB 231 and MCF-7 breast cancer cells with IC50 values below 100 nM. Though they exhibited similar structure-activity relationships as the aldehydes, they did not inhibit tubulin polymerization but were capable of blocking the cell cycle in G(2)/M phase. The cell cycle arrest was accompanied by apoptosis as demonstrated by the activation of caspases 3 and 9. Since the new 2-phenylindole derivatives also inhibited the growth of transplanted MXT mouse mammary tumors, they are interesting candidates for further development. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7368 / 7379
页数:12
相关论文
共 28 条
  • [1] Substituted E-3-(2-chloro-3-indolylmethylene)1, 3-dihydroindol-2-ones with antitumor activity
    Andreani, A
    Granaiola, M
    Leoni, A
    Locatelli, A
    Morigi, R
    Rambaldi, M
    Garaliene, V
    Farruggia, G
    Masotti, L
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (05) : 1121 - 1128
  • [2] Clinical anticancer drug development: targeting the cyclin-dependent kinases
    Benson, C
    Kaye, S
    Workman, P
    Garrett, M
    Walton, M
    de Bono, J
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (01) : 7 - 12
  • [3] Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines:: comparisons with the National Cancer Institute data
    Bracht, K
    Boubakari
    Grünert, R
    Bednarski, PJ
    [J]. ANTI-CANCER DRUGS, 2006, 17 (01) : 41 - 51
  • [4] Cell cycle molecular targets in novel anticancer drug discovery
    Buolamwini, JK
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (04) : 379 - 392
  • [5] Proteases for cell suicide: Functions and regulation of caspases
    Chang, HY
    Yang, XL
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2000, 64 (04) : 821 - +
  • [6] Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling
    Cover, CM
    Hsieh, SJ
    Tran, SH
    Hallden, G
    Kim, GS
    Bjeldanes, LF
    Firestone, GL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (07) : 3838 - 3847
  • [7] Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine
    Eisenbrand, G
    Hippe, F
    Jakobs, S
    Muehlbeyer, S
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (11) : 627 - 635
  • [8] Indole-3-carbinol (I3C) inhibits cyclin-dependent kinase-2 function in human breast cancer cells by regulating the size distribution, associated cyclin E forms, and subcellular localization of the CDK2 protein complex
    Garcia, HH
    Brar, GA
    Nguyen, DHH
    Bjeldanes, LF
    Firestone, GL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (10) : 8756 - 8764
  • [9] Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization
    Gastpar, R
    Goldbrunner, M
    Marko, D
    von Angerer, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) : 4965 - 4972
  • [10] Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells
    Hong, C
    Firestone, GL
    Bjeldanes, LF
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 63 (06) : 1085 - 1097